Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
14.01. | Enhanc3D Genomics Launches Suite of Integrated Multi-Omics Solutions | ||
14.01. | Sapio Sciences Upgrades Informatics Platform with Release 24.12 | ||
14.01. | Vetter to Introduce New V-OVS Syringe Closure System | ||
14.01. | Hikma Partners with Emergent for the Sale of KLOXXADO in the U.S. & Canada | ||
14.01. | Touchlight's Hampton, UK Facility Receives GMP Certification from MHRA | ||
14.01. | Cube Biotech Acquires IBA Lifesciences | ||
14.01. | BioMedX Launches Collaboration with Daiichi Sankyo to Explore New Approaches in Cancer Treatment | ||
13.01. | Quadria Capital Invests $100M in Aragen to Expand CRDMO Services | ||
13.01. | Biohaven & Merus Team Up to Develop Novel Bispecific ADC Therapies | ||
13.01. | GSK Agrees to Acquire IDRx | ||
13.01. | Alcami Announces CEO Transition | ||
13.01. | AbbVie, Simcere Zaiming Partner to Develop Trispecific Antibody in Multiple Myeloma | ||
13.01. | ILC Dover Launches Sentinel XT Horizon | ||
13.01. | Synthego, AstraZeneca Ink Agreement for CRISPR Gene Editing Enzyme | ||
13.01. | SpringWorks to Develop Rappta's First-in-Class Cancer Drug | ||
13.01. | Iconovo, Lonza Partner to Develop Spray-Dried Formulations | ||
13.01. | Canyon Labs Acquires iuvo BioScience's Lab Services and Consulting Biz | ||
13.01. | Telix to Acquire Pipeline, Technology Platform & Facility from ImaginAb | ||
13.01. | Gilead, LEO Pharma Partner to Accelerate Development of Oral STAT6 Program | ||
13.01. | Johnson & Johnson Agrees to Acquire Intra-Cellular Therapies | ||
10.01. | Abzena Welcomes Dr. Moncef Slaoui to Its Board of Directors | ||
10.01. | Verdiva Bio Launches as Clinical-Stage Cardiometabolic Company | ||
10.01. | Nucleus Biologics Achieves EXCiPACT Certification | ||
10.01. | BioDuro Opens New Peptide Laboratory in Shanghai | ||
10.01. | Esphera SynBio Launches Project to Enhance mRNA Vaccines |